Affiliation: University of California
- Estrogen augmentation of antidepressants in perimenopausal depression: a pilot studyMelinda L Morgan
Laboratory of Behavioral Pharmacology, University of California Los Angeles Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, 90024, USA
J Clin Psychiatry 66:774-80. 2005..To investigate the effects of estrogen augmentation on mood and memory in women with perimenopausal depression who had experienced a partial response to antidepressant medications...
- Cognitive flexibility, reaction time, and attention in women with premenstrual dysphoric disorderMelinda Morgan
Department of Adult Psychiatry, University of California, Los Angeles, USA
J Gend Specif Med 5:28-36. 2002..RESEARCH HYPOTHESIS: Measures of cognitive function will discriminate between women with prospectively documented PDD and women without PDD during the late-luteal phase of the menstrual cycle...
- Neurophysiologic changes during estrogen augmentation in perimenopausal depressionMelinda L Morgan
Laboratory of Brain, Behavior, and Pharmacology, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, 760 Westwood Plaza, Suite 37 439, Los Angeles, CA 90024 1759, United States
Maturitas 56:54-60. 2007..We also assessed whether such changes were correlated with serum hormone levels...
- Early changes in prefrontal activity characterize clinical responders to antidepressantsIan A Cook
Quantitative EEG Laboratory, Neuropsychiatric Institute and Hospital, UCLA School of Medicine, University of California, 760 Westwood Plaza, Los Angeles, CA 90024 1759, USA
Neuropsychopharmacology 27:120-31. 2002..These findings implicate the prefrontal region in mediating response to antidepressant medications. Cordance may have clinical applicability as a leading indicator of individual response...
- Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depressionAndrew F Leuchter
UCLA NPI, 760 Westwood Plaza, Suite 37 452, Los Angeles, CA 90024 1759, USA
Psychopharmacology (Berl) 177:15-22. 2004..High placebo response rates are a confound in treatment trials for major depressive disorder (MDD). A method for prospective identification of placebo responders could enhance the efficiency of clinical trials...
- Elevated gray matter volume of the emotional cerebellum in women with premenstrual dysphoric disorderSteven M Berman
Department of Psychiatry and Biobehavioral Sciences, University of California Los Angele, CA 90095, USA
J Affect Disord 146:266-71. 2013..We extended this work with a study of brain structure in PMDD...
- Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressantHeather V Krell
Laboratory of Behavioral Pharmacology, UCLA Neuropsychiatric Institute, and the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024 1759, USA
J Clin Psychiatry 65:1174-9. 2004..To evaluate the association between treatment expectations and response in a 9-week, single-blind experimental antidepressant treatment study...
- Pretreatment neurophysiologic function and ECT response in depressionWilliam F Stubbeman
Laboratory of Behavioral Pharmacology, UCLA Neuropsychiatric Institute, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA
J ECT 20:142-4. 2004..The present study tested the hypothesis that brain activity in midline apical quantitative EEG (QEEG) electrodes would be associated with therapeutic response to electroconvulsive therapy (ECT)...
- Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorderAndrea J Rapkin
Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California 90095 1740, USA
Biol Psychiatry 69:374-80. 2011..Despite a prevalence of up to 8% in women of reproductive age, few studies have investigated the brain mechanisms that underlie this disorder...
- Changes in brain function of depressed subjects during treatment with placeboAndrew F Leuchter
UCLA Neuropsychiatric Institute, Los Angeles, CA 90024 1759, USA
Am J Psychiatry 159:122-9. 2002..Both QEEG power and cordance, a new measure that reflects cerebral perfusion and is sensitive to the effect of antidepressant medication, were examined...
- Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changesAndrea J Rapkin
Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095 1740, USA
Fertil Steril 85:1371-8. 2006..These neuroactive steroids are gamma-aminobutyric acid receptor agonists and are important in the modulation of affect and adaptation to stress...
- Multilevel local anesthetic nerve blockade for the treatment of vulvar vestibulitis syndromeAndrea J Rapkin
Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA Los Angeles, CA, USA
Am J Obstet Gynecol 198:41.e1-5. 2008..Vulvar vestibulitis syndrome is a major cause of dyspareunia. This pilot study was designed to evaluate a novel treatment approach...